CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease

[1]  S. Stumpf,et al.  Cholesterol in myelin biogenesis and hypomyelinating disorders. , 2015, Biochimica et biophysica acta.

[2]  Huadong Zhou,et al.  CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease , 2013, Journal of Neurology.

[3]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[4]  Zhenxin Zhang,et al.  An Intronic CYP46A1 Polymorphism Is Associated with Alzheimer Disease in a Chinese Han Population , 2012, Journal of Molecular Neuroscience.

[5]  C. Dotti,et al.  Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons , 2011, Neurobiology of Aging.

[6]  M. Grimaldi,et al.  Interaction of a β‐sheet breaker peptide with lipid membranes , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[7]  R. Martins,et al.  Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.

[8]  Ariadna Besga,et al.  Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease , 2009, Neuroscience Letters.

[9]  Anália Nusya Medeiros Garcia,et al.  Cyp46 Polymorphisms in Alzheimer’s Disease: A Review , 2009, Journal of Molecular Neuroscience.

[10]  F. Jessen,et al.  CYP46A1 variants influence Alzheimer’s disease risk and brain cholesterol metabolism , 2009, European Psychiatry.

[11]  G. Vitiello,et al.  Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol. , 2008, Biochimica et biophysica acta.

[12]  J. Jia,et al.  Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese , 2007, Brain Research.

[13]  B. Cheung,et al.  Intron 2 (T/C) CYP46 Polymorphism Is Associated with Alzheimer’s Disease in Chinese Patients , 2006, Dementia and Geriatric Cognitive Disorders.

[14]  S. Sorbi,et al.  Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease , 2006, Neurobiology of Aging.

[15]  H. Chiu,et al.  Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population , 2006, International Psychogeriatrics.

[16]  H. Soininen,et al.  Association of CYP46 intron 2 polymorphism in Finnish Alzheimer’s disease samples and a global scale summary , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  F. LaFerla,et al.  Alzheimer's disease: Aβ, tau and synaptic dysfunction , 2005 .

[18]  C. Caltagirone,et al.  Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators , 2004, Neurobiology of Aging.

[19]  K. Fassbender,et al.  Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide , 2002, Neurology.

[20]  P. S. St George-Hyslop.  Genetic Factors in the Genesis of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[21]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[22]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[23]  F. Jessen,et al.  Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. , 2000, Journal of lipid research.

[24]  J M Guileyardo,et al.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Wahren,et al.  Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. , 1998, Journal of lipid research.

[26]  D. Lütjohann,et al.  Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[28]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[29]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[30]  A. Chobanian,et al.  Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. , 1962, The Journal of clinical investigation.

[31]  L. Bertram.  Alzheimer's disease genetics: Current status and future perspectives , 2009, Alzheimer's & Dementia.

[32]  L. Bertram.  Alzheimer's disease genetics current status and future perspectives. , 2009, International review of neurobiology.

[33]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[34]  Frank M LaFerla,et al.  Alzheimer's disease: Abeta, tau and synaptic dysfunction. , 2005, Trends in molecular medicine.

[35]  H. Braak,et al.  Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. , 2003, Archives of neurology.

[36]  F. Licastro,et al.  Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. , 2002, Journal of Alzheimer's disease : JAD.

[37]  F. Jessen,et al.  24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. , 2002, Journal of psychiatric research.

[38]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.